Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
LIGAND PHARMACEUTICALS INC has filed 2,270 SEC EDGAR filings since 13 Sep 1994

SEC filing history

Showing 676-700 of 1,000 matching filings.

Per page
25
Current page
28
8-K File 001-33093

8K

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Oct 2018
Reporting date
24 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Oct 2018
Reporting date
12 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Oct 2018
Reporting date
11 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
10 Oct 2018
Reporting date
10 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Oct 2018
Reporting date
08 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
09 Oct 2018
Reporting date
08 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Oct 2018
Reporting date
01 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Oct 2018
Reporting date
01 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-37355

FORM 4 SUBMISSION

Filing date
27 Sep 2018
Reporting date
13 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
24 Sep 2018
Reporting date
24 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Sep 2018
Reporting date
17 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Aug 2018
Reporting date
30 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Aug 2018
Reporting date
29 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33093

CT ORDER filing

Filing date
24 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Aug 2018
Reporting date
16 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Aug 2018
Reporting date
16 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Aug 2018
Reporting date
16 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Aug 2018
Reporting date
16 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
09 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .